PET imaging of pulmonary sarcoidosis

• Conditions: Pulmonary sarcoidosis with active garnulomas in the lungs. The diagnosis is based on the clinical evidence or biopsy.; MedDRA version: 18.1Level: PTClassification code 10037430Term: Pulmonary sarcoidosisSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disorders; Therapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Diagnosis [E01]

• Registration Number: EUCTR2015-001815-11-FI
• Lead Sponsor: Turku PET Centre

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2015-12-29
• Last Update Posted: 2 May 2016

Recruitment & Eligibility

• Status: Authorised-recruitment may be ongoing or finished
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

1)Male or female patients with sarcoidosis . Diagnosis is primarily based on the clinical evidence and if atypical it is confirmed by biopsy.
2)Age > 18 years

Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 10
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

1)Any malignant disease
2)Any significant other inflammatory or infectious disease affecting lungs
3)Pregnancy or lactation
4)Physical, psychological, or logistic problems to participate in all protocol-defined procedures

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified